We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$152B
AUM Growth
+$4.77B
Cap. Flow
+$2.89B
Cap. Flow %
1.9%
Top 10 Hldgs %
26.78%
Holding
4,133
New
185
Increased
1,882
Reduced
1,701
Closed
184

Sector Composition

Rank Sector Weight
1 Technology 17.11%
2 Financials 8.61%
3 Healthcare 7.69%
4 Industrials 6.49%
5 Consumer Discretionary 5.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EAF icon
3726
GrafTech
EAF
$204M
$95.5K ﹤0.01%
9,850
+140
+1% +$2.15K
HNST icon
3727
The Honest Company
HNST
$558M
$95.1K ﹤0.01%
32,562
-4,501
-12% -$13.4K
GDL
3728
GDL Fund
GDL
$92M
$94.9K ﹤0.01%
12,109
-4,281
-26% -$33.6K
GGB icon
3729
Gerdau
GGB
$9.23B
$94.9K ﹤0.01%
28,758
-5,041
-15% -$17.8K
T icon
3730
PUT
AT&T
T
$167B
$94.5K ﹤0.01%
6,300
NHS
3731
Neuberger High Yield Strategies Fund Inc
NHS
$254M
$94.4K ﹤0.01%
12,072
-7
-0.1% -$56
ACCD
3732
DELISTED
Accolade Inc
ACCD
$93.8K ﹤0.01%
26,192
+267
+1% +$2.02K
GSAT icon
3733
Globalstar
GSAT
$10.8B
$93K ﹤0.01%
5,537
-100
-2% -$1.8K
PBI icon
3734
Pitney Bowes
PBI
$2.29B
$91.4K ﹤0.01%
17,997
-8,852
-33% -$42.3K
MGF
3735
Aberdeen Government Markets Income Fund
MGF
$92.2M
$89.9K ﹤0.01%
29,294
+440
+2% +$1.36K
MRCC
3736
DELISTED
Monroe Capital Corp
MRCC
$89.7K ﹤0.01%
11,792
+765
+7% +$5.65K
AUPH icon
3737
Aurinia Pharmaceuticals
AUPH
$2.05B
$89.6K ﹤0.01%
15,700
-2,001
-11% -$10.5K
FBLG icon
3738
FibroBiologics
FBLG
$6.72M
$88K ﹤0.01%
+882
New +$168K
ASG
3739
Liberty All-Star Growth Fund
ASG
$345M
$88K ﹤0.01%
16,481
-844
-5% -$4.43K
ACTG icon
3740
Acacia Research
ACTG
$452M
$85.7K ﹤0.01%
17,102
+302
+2% +$1.56K
HIMX
3741
Himax Technologies
HIMX
$2.63B
$85.1K ﹤0.01%
10,717
-201
-2% -$1.23K
LAW icon
3742
CS Disco
LAW
$277M
$84.2K ﹤0.01%
14,130
-1,000
-7% -$6.91K
AGL icon
3743
Agilon Health
AGL
$1.52B
$83K ﹤0.01%
507
-22
-4% -$3.13K
FINV
3744
FinVolution Group
FINV
$1.05B
$82.9K ﹤0.01%
17,376
GLQ
3745
Clough Global Equity Fund
GLQ
$157M
$81.8K ﹤0.01%
11,725
+353
+3% +$2.31K
COUR icon
3746
Coursera
COUR
$1.49B
$80.6K ﹤0.01%
+11,258
New +$107K
DY icon
3747
PUT
Dycom Industries
DY
$12.2B
$80K ﹤0.01%
+500
New +$78K
GLV
3748
Clough Global Dividend & Income Fund
GLV
$78.6M
$78.8K ﹤0.01%
13,818
-2,674
-16% -$14.8K
CNTY icon
3749
Century Casinos
CNTY
$34.3M
$78.4K ﹤0.01%
28,300
EOD
3750
Allspring Global Dividend Opportunity Fund
EOD
$286M
$77.7K ﹤0.01%
15,992
-2,500
-14% -$11.8K

Similar funds

Raymond James & Associates's Q2 2024 Portfolio in Review

As of Q2 2024, Raymond James & Associates held 4,133 positions worth $152B, up 3.2% from $148B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Raymond James & Associates's Q2 2024 filing shows 185 new, 1,882 increased, 1,701 reduced and 184 closed positions. Its largest new stake was Solventum: 321,226 shares worth $17M. The largest sale was State Street Health Care Select Sector SPDR ETF, an estimated $157M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2024 buy was Solventum: 321,226 shares worth $17M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q2 2024, an estimated $255M increase.
  • Raymond James & Associates's biggest Q2 2024 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $157M.
  • Raymond James & Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $110M.
  • Raymond James & Associates's ten largest holdings make up 27% of its $152B portfolio in Q2 2024.
  • Raymond James & Associates opened 185 new positions and closed 184 in Q2 2024.
  • Raymond James & Associates's portfolio value rose 3.2% quarter-over-quarter to $152B.

Based on Raymond James & Associates's 13F filing for Q2 2024, filed 19 Jul 2024.